Will Vaxcyte announce the initiation of a Phase 3 trial for VAX-31 by March 31, 2025? | Binary | | | 4 months ago | |
Will Vaxcyte's market cap exceed $10 billion by June 30, 2025? | Binary | | | 4 months ago | |
Will Vaxcyte's stock price exceed $100 by December 31, 2024? | Binary | | | 4 months ago | |
Will Vaxcyte's VAX-31 receive FDA approval for use in adults aged 50 and older by September 3, 2025? | Binary | | | 4 months ago | |
Will Vaxcyte's VAX-31 advance to Phase 3 trials by June 30, 2025? | Binary | | | 4 months ago | |
Will Vaxcyte's VAX-31 receive FDA Breakthrough Therapy designation by December 31, 2024? | Binary | | | 4 months ago | |
Will Vaxcyte's market cap exceed $20 billion by December 31, 2024? | Binary | | | 4 months ago | |
Will Vaxcyte's stock price exceed $150 by the end of 2024? | Binary | | | 4 months ago | |
What will be Vaxcyte's stock price at the end of Q4 2024? | Categorical | | | 4 months ago | |
Will Vaxcyte announce a partnership with a major pharmaceutical company by March 31, 2025? | Binary | | | 4 months ago | |
What will be Vaxcyte's revenue for the fiscal year 2024? | Categorical | | | 4 months ago | |
What will be Vaxcyte's market cap at the end of 2024? | Categorical | | | 4 months ago | |
Which company will have the highest market share in the PCV market by the end of 2025? | Categorical | | | 4 months ago | |
What will be the peak sales estimate for Vaxcyte's VAX-31 by the end of 2025? | Categorical | | | 4 months ago | |
What will be the outcome of Vaxcyte's Phase 3 trial for VAX-31 by December 31, 2024? | Categorical | | | 4 months ago | |
What will be Vaxcyte's market cap ranking among biotech companies by September 3, 2025? | Categorical | | | 4 months ago | |
What will be the next major milestone for Vaxcyte's VAX-31 by December 31, 2024? | Categorical | | | 4 months ago | |
How will the Vaxcyte's VAX-31 Phase 1/2 study results be presented in the webcast? | Categorical | | | 4 months ago | |
